Cargando…
Targeted α Therapies for the Treatment of Bone Metastases
The skeleton is the target tissue for many types of tumors, and, recently, the survival of patients with prostate cancer metastasis has been increased using α-emitting drugs known as targeted α therapies. The use of α-radiopharmaceuticals in medicine was hypothesized at the beginning of the nineteen...
Autores principales: | Zustovich, Fable, Barsanti, Roberto |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5796024/ https://www.ncbi.nlm.nih.gov/pubmed/29283383 http://dx.doi.org/10.3390/ijms19010074 |
Ejemplares similares
-
Clinical experience and critical evaluation of the role of sorafenib in renal cell carcinoma
por: Zustovich, Fable, et al.
Publicado: (2011) -
The Combination of Carmustine Wafers and Fotemustine in Recurrent Glioblastoma Patients: A Monoinstitutional Experience
por: Lombardi, Giuseppe, et al.
Publicado: (2014) -
Advancing Treatment of Bone Metastases through Novel Translational Approaches Targeting the Bone Microenvironment
por: Sethakorn, Nan, et al.
Publicado: (2022) -
Therapeutic targets for bone metastases in breast cancer
por: Clézardin, Philippe
Publicado: (2011) -
The role of radiation therapy in bone metastases management
por: Felice, Francesca De, et al.
Publicado: (2017)